BB-1705

Bliss Biopharmaceutical (Hangzhou) Co., Ltd · Phase 1 active Small molecule

At a glance

Generic name	BB-1705
Sponsor	Bliss Biopharmaceutical (Hangzhou) Co., Ltd
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

BB-1705 CI brief — competitive landscape report
BB-1705 updates RSS · CI watch RSS
Bliss Biopharmaceutical (Hangzhou) Co., Ltd portfolio CI